Balwani MR et al., 2017: Case report of a patient given methylene blue for nitrobenzene poisoning who then developed methemoglobinemia with acute kidney injury from haemolysis and was found to be G6PD deficient; he was treated with repeated transfusions, ascorbic acid and dialysis.
After which he developed methemoglobinemia with acute kidney injury due to hemolysis and on further testing, he was found to be glucose-6-phosphate dehydrogenase (G6PD) enzyme deficient.
Balwani MR et al., 2017: Case report of a patient given methylene blue for nitrobenzene poisoning who then developed methemoglobinemia with acute kidney injury from haemolysis and was found to be G6PD deficient; he was treated with repeated transfusions, ascorbic acid and dialysis. C3 and C5. Dose/route: intravenous methylene blue as antidote for nitrobenzene-induced methemoglobinemia (mg/kg not given in the abstract; full text on PMC). Funder/conflicts: not stated in abstract. Comparator: none. The case shows the harm the label contraindication is written to prevent, and the paradox that methylene blue itself produced methemoglobinemia. Also filed as MTQ-087 (claims C3, C9). Study type: case report.
